Moffitt | Strategic Alliance Partners

Latest from Moffitt

Dr. Sweet on Key Findings From the OPTIC Trial With Ponatinib in CML

January 19, 2021

Video

Kendra Sweet, MD, discusses key findings from the OPTIC trial with ponatinib in chronic myeloid leukemia.

Emerging Therapies May Offer Fresh Options for TP53-Mutated MDS

January 13, 2021

Article

Two novel treatments options may shake up the landscape for treating patients with myelodysplasia syndrome.

Dr. Sweet on Treatment Selection With TKIs in CML

December 15, 2020

Video

Kendra Sweet, MD, discusses treatment selection with TKIs in chronic myeloid leukemia.

Moffitt Expert Emphasizes Need to Improve Sarcoma Diagnoses

November 19, 2020

Article

Marilyn M. Bui, MD, PhD, highlights the importance of pathology in sarcoma and how it is the cornerstone of precision medicine.

Immunotherapy Combos Continue to Excel in NSCLC, But Patient Selection Must Be Optimized

October 23, 2020

Article

In an interview with OncLive® Michael Shafique, MD, discusses examples of this groundbreaking research of immunotherapy combinations in NSCLC.

COVID-19 Raises the Stakes of Preventive Medicine in Oncology

October 13, 2020

Article

Anna Giuliano, PhD, discusses the work efforts to advance the reach of preventive vaccines and cancers, and the challenges researchers are facing in the process.